Question 1

Publications

Accepted Answer

Menter A, Gelfand JM, Connor C, Armstrong AW, Cordoro KM, Davis DMR, Elewski BE, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Lebwohl M, Leondardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Prater EF, Rahimi RS, Rupani RN, Siegel M, Stoff B, Strober BE, Tapper EB, Wong EB, Wu JJ, Hariharan V, Elmets CA. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with Systemic Non-Biological Therapies. J Am Acad Dermatol. 2020 Feb 21
 
Menter A, Cordoro KM, Davis DMR, Kroshinsky D, Paller S, Armstrong AW, Connor C, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NM, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Elmets CA. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020 Jan;82(1):161-201.
 
Elmets CA, Lim HW, Stoff B, Connor C, Cordoro KM, Lebwohl M, Armstrong AW, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Leonardi CL, Lichten J, Mehta NM, Paller AS, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Strober BE, Wong EB, Wu JJ, Hariharan V, Menter A. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with phototherapy. J Am Acad Dermatol. 2019 Sept;81(3):775-804.
 
Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kavanaugh A, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Rupani RN, Siegel M, Wong EB, Wu JJ, Hariharan V, Elmets CA. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019 Apr;80(4):1029-1072.
 
Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, Armstrong AW, Connor C, Cordoro KM, Elewski BE, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kivelevitch D, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Lim HW, Paller AS, Parra SL, Pathy AL, Prater EF, Rupani R, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Menter A. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019 Apr;80(4):1073-1113. 
Prater EF, Day A, Patel M, Menter A. A retrospective analysis of 72 patients on prior efalizumab subsequent to the time of voluntary market withdrawal in 2009. J Drugs Dermatol. 2014 Jun;13(6):712-8.
 
Farley E, Menter A. Psoriasis: Comorbidities and Associations. G Ital Dermatol Venereol. 2011 Feb; 146(1):9-15. 
 
Farley E, Masrour S, McKey J, Menter A. Palmoplantar Psoriasis: A historical and clinical review with introduction of a new quality of life assessment tool. J Am Acad Dermatol 2009 June; 60(6):1024-31.
 
Menter A, Kamili Q, and Farley E. Get under the skin: diagnosis and treatment of psoriasis, and guidelines for specialist referrals. Medical Economics 2009 July.

Question 2

Presentations

Accepted Answer

Prater EF. "Systemic Contact Dermatitis: Presentation, Clues and Culprits." University of Oklahoma Department of Dermatology Grand Rounds. April 25, 2019.
 
Farley E, Cockerell C. “Calciphylaxis in a patient with POEMS syndrome in the absence of renal failure.” American Academy of Dermatology gross and microscopic conference. February 5, 2011.
 
Farley E, Champion R, Chon S. “Prominent Acantholytic Dyskeratosis in Pemphigus Vulgaris Masquerading Clinically as Squamous Cell Carcinoma.” Presented at the 57th annual Zola Cooper Seminar. November 13th, 2010.
 
Farley E, Hebert A. “Lamellar Ichthyosis” presented at the Houston Dermatological Society’s John M. Knox Lecture in Houston, Texas. November 21, 2010.
 
Farley E, Rapini R. “Keratoacanthoma-like lesions on Bosutinib Therapy.” Presented at the Texas Dermatological Society Meeting in Austin, Texas. May 2, 2009.
 
Farley E, Rapini R, Hebert A. “Incontinentia Pigmentii” presented at the Houston Dermatological Society Meeting in Houston, Texas. December 8, 2008.
 
Farley E, Giancola A, Mays S. “CREST syndrome” presented at the Houston Dermatological Society’s John M. Knox Lecture in Houston, Texas. October 7, 2006.

Question 3

Posters

Accepted Answer

Farley E, Emmett M, and Armstrong M. “Leukemia Cutis: A Sign of Recurrent Acute Myeloid Leukemia” American College of Physicians-American Society of Internal Medicine meeting in Dallas, Texas May 7, 2008.

Question 4

Honors / Awards

Accepted Answer

Women’s Dermatologic Mentorship Award, Spring 2011
International Psoriasis Council Future Leaders Program, 2009
University of Texas at Houston Outstanding Student in Dermatology, spring 2007
Junior Alpha Omega Alpha, spring 2006
Phi Beta Kappa, spring 2003
Tau Beta Pi, Engineering Honors Society, fall 2001
University of Rochester Forbes Engineering Entrepreneurship Competition 1st place, 2003

Question 5

Professional and Educational Involvement

Accepted Answer

Assistant Professor of Dermatology at the University of Oklahoma Health Science Center 2013 - current
Fellow of the American Academy of Dermatology, fall 2011 - current
Member of the Women’s Dermatologic Society, spring 2009 – current
Member of the American Medical Association –  2004 - current
Journal of Drugs in Dermatology Case Report Reviewer, fall 2009 - fall 2014

Professional Accomplishments